{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00771669,0.001181005,0.001702522,0.0003605863,0.0004263147,0.001247496,0.0005448989,0.0008523693,0.007759927],"category_scores_gemma":[0.004335498,0.000485398,0.003733375,0.0003321024,0.0003929534,0.0005932746,0.0004315696,0.002198295,0.001129687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007286838,"about_ca_system_score_gemma":0.002147507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003422427,"about_ca_topic_score_gemma":0.001139515,"domain_scores_codex":[0.9969215,0.00188594,0.0001483715,0.000329856,0.0003211724,0.0003931347],"domain_scores_gemma":[0.9975247,0.0008588855,0.0007073269,0.000372319,0.000186808,0.0003500206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8557347,0.008406758,0.02163962,0.000831515,0.004830241,0.0002833608,0.0001305457,0.007008335,0.01600726,0.0008216046,0.02400035,0.06030567],"study_design_scores_gemma":[0.3930874,0.4099294,0.1066519,0.0002013784,0.008972457,0.0008359815,0.000159887,0.01460616,0.02416239,0.003344568,0.0378986,0.000150012],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9405537,0.003117868,0.006518967,0.001439719,0.0006062997,0.009351023,0.02358409,0.0004857221,0.01434271],"genre_scores_gemma":[0.9486127,0.0006591468,0.008932723,0.002229493,0.0002400268,0.01342981,0.01922468,0.0002096344,0.006461651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007759927,"threshold_uncertainty_score":0.04081023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02856484540316573,"score_gpt":0.270789013981223,"score_spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}